71 related articles for article (PubMed ID: 38592299)
1. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with
Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580
[No Abstract] [Full Text] [Related]
2. ATTR Amyloidosis: Current and Emerging Management Strategies:
Griffin JM; Rosenthal JL; Grodin JL; Maurer MS; Grogan M; Cheng RK
JACC CardioOncol; 2021 Oct; 3(4):488-505. PubMed ID: 34729521
[TBL] [Abstract][Full Text] [Related]
3. Cardio-Hepatic Interaction in Cardiac Amyloidosis.
Ihne-Schubert SM; Goetze O; Gerstendörfer F; Sahiti F; Schade I; Papagianni A; Morbach C; Frantz S; Einsele H; Knop S; Sommer C; Müllhaupt B; Schubert T; Störk S; Geier A
J Clin Med; 2024 Mar; 13(5):. PubMed ID: 38592299
[No Abstract] [Full Text] [Related]
4. Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value.
Cipriani A; De Michieli L; Porcari A; Licchelli L; Sinigiani G; Tini G; Zampieri M; Sessarego E; Argirò A; Fumagalli C; De Gaspari M; Licordari R; Russo D; Di Bella G; Perfetto F; Autore C; Musumeci B; Canepa M; Merlo M; Sinagra G; Gregori D; Iliceto S; Perazzolo Marra M; Cappelli F; Rapezzi C
JACC CardioOncol; 2022 Nov; 4(4):458-470. PubMed ID: 36444225
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study.
Nicol M; Vergaro G; Damy T; Kharoubi M; Baudet M; Canuti ES; Aimo A; Castiglione V; Emdin M; Royer B; Harel S; Cohen-Solal A; Arnulf B; Logeart D
Front Cardiovasc Med; 2023; 10():1179968. PubMed ID: 37600055
[TBL] [Abstract][Full Text] [Related]
6. Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population: A Pilot Study.
Singal AK; Bansal R; Singh A; Dorbala S; Sharma G; Gupta K; Saxena A; Bhargava B; Karthikeyan G; Ramakrishnan S; Bisoi AK; Hote MP; Rajashekar P; Chowdhury UK; Devagourou V; Patel C; Ray R; Arawa SK; Mishra S
JACC CardioOncol; 2021 Oct; 3(4):565-576. PubMed ID: 34746852
[TBL] [Abstract][Full Text] [Related]
7. [18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions.
Genovesi D; Vergaro G; Giorgetti A; Marzullo P; Scipioni M; Santarelli MF; Pucci A; Buda G; Volpi E; Emdin M
JACC Cardiovasc Imaging; 2021 Jan; 14(1):246-255. PubMed ID: 32771577
[TBL] [Abstract][Full Text] [Related]
8. Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS).
Kristen AV; Maurer MS; Rapezzi C; Mundayat R; Suhr OB; Damy T;
PLoS One; 2017; 12(4):e0173086. PubMed ID: 28384285
[TBL] [Abstract][Full Text] [Related]
9. How well does liver span as part of the consensus criteria for liver involvement in AL amyloidosis perform?
Brunger AF; van Rheenen R; Gans ROB; Hazenberg BPC; Nienhuis HLA
Amyloid; 2023 Dec; 30(4):437-439. PubMed ID: 37318263
[No Abstract] [Full Text] [Related]
10. Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study.
Tini G; Milani P; Zampieri M; Caponetti AG; Fabris F; Foli A; Argirò A; Mazzoni C; Gagliardi C; Longhi S; Saturi G; Vergaro G; Aimo A; Russo D; Varrà GG; Serenelli M; Fabbri G; De Michieli L; Palmiero G; Ciliberti G; Carigi S; Sessarego E; Mandoli GE; Ricci Lucchi G; Rella V; Monti E; Gardini E; Bartolotti M; Crotti L; Merli E; Mussinelli R; Vianello PF; Cameli M; Marzo F; Guerra F; Limongelli G; Cipriani A; Perlini S; Obici L; Perfetto F; Autore C; Porto I; Rapezzi C; Sinagra G; Merlo M; Musumeci B; Emdin M; Biagini E; Cappelli F; Palladini G; Canepa M
Eur J Heart Fail; 2023 Jun; 25(6):845-853. PubMed ID: 36907828
[TBL] [Abstract][Full Text] [Related]
11. Vibration-controlled Transient Elastography in NAFLD: Review Study.
Ozercan AM; Ozkan H
Euroasian J Hepatogastroenterol; 2022 Jul; 12(Suppl 1):S41-S45. PubMed ID: 36466098
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the cardiac amyloidosis clinical pathway implementation: a real-world experience.
Brons M; Muller SA; Rutten FH; van der Meer MG; Vrancken AFJE; Minnema MC; Baas AF; Asselbergs FW; Oerlemans MIFJ
Eur Heart J Open; 2022 Mar; 2(2):oeac011. PubMed ID: 35919127
[TBL] [Abstract][Full Text] [Related]
13. European guideline on indications, performance and clinical impact of
Keller J; Hammer HF; Afolabi PR; Benninga M; Borrelli O; Dominguez-Munoz E; Dumitrascu D; Goetze O; Haas SL; Hauser B; Pohl D; Salvatore S; Sonyi M; Thapar N; Verbeke K; Fox MR;
United European Gastroenterol J; 2021 Jun; 9(5):598-625. PubMed ID: 34128346
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of the
Fontana RJ; Stravitz RT; Durkalski V; Hanje J; Hameed B; Koch D; Reuben A; Ganger D; Olson J; Liou I; McGuire BM; Clasen K; Lee WM
Hepatology; 2021 Aug; 74(2):961-972. PubMed ID: 33660316
[TBL] [Abstract][Full Text] [Related]
15. Diuretic Dose and NYHA Functional Class Are Independent Predictors of Mortality in Patients With Transthyretin Cardiac Amyloidosis.
Cheng RK; Levy WC; Vasbinder A; Teruya S; De Los Santos J; Leedy D; Maurer MS
JACC CardioOncol; 2020 Sep; 2(3):414-424. PubMed ID: 33073249
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
